CYP2C9andABCG2polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study

Genetic Polymorphisms in ABCB1 Influence the Pharmacodynamics of Tacrolimus

(2013) Ramin Vafadari et al.   THERAPEUTIC DRUG MONITORING

Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation

(2012) L. V. Riella et al.   AMERICAN JOURNAL OF TRANSPLANTATION

TheCYP3A4*22allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations

(2012) Laure Elens et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

(2012) R A Wilke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors

(2012) Mukul Minocha et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical Drugs Undergoing Polymorphic Metabolism by Human Cytochrome P450 2C9 and the Implication in Drug Development

(2011) S.-M. He et al.   CURRENT MEDICINAL CHEMISTRY

The Challenge of Exploiting ABCG2 in the Clinic

(2011) Robert W. Robey et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia

(2011) Andreas Holstein et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin

(2011) L R Brunham et al.   PHARMACOGENOMICS JOURNAL

Genetic involvement in statins induced myopathy. Preliminary data from an observational case–control study

(2010) Luca Puccetti et al.   ATHEROSCLEROSIS

Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy

(2010) Yiannis S. Chatzizisis et al.   DRUG SAFETY

Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows

(2010) LAURENT EXCOFFIER et al.   Molecular Ecology Resources

Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient

(2010) N. Basic-Jukic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin

(2009) Jenni E. Keskitalo et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of OATP transporters on pharmacokinetics

(2009) A Kalliokoski et al.   BRITISH JOURNAL OF PHARMACOLOGY

Transporter Pharmacogenetics and Statin Toxicity

(2009) M Niemi   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance

(2009) Bo Wang et al.   CURRENT DRUG METABOLISM

Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration

(2009) Kimberly K. Adkison et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects

(2009) Deepak Voora et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation

(2009) F. P. Hurst et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effects of α-Adrenoceptor Antagonist Doxazosin on MDR1-Mediated Multidrug Resistance and Transcellular Transport

(2009) Kohji Takara et al.   ONCOLOGY RESEARCH

Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

(2009) Jenni E Keskitalo et al.   PHARMACOGENOMICS

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

(2009) S P R Romaine et al.   PHARMACOGENOMICS JOURNAL

Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin With Rapamycin Plus Tacrolimus in Liver Transplant Patient

(2009) C. Dopazo et al.   TRANSPLANTATION PROCEEDINGS

Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy

(2008) Kunihiro Suzuki et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Differential Genotype Dependent Inhibition of CYP2C9 in Humans

(2008) V. Kumar et al.   DRUG METABOLISM AND DISPOSITION

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE